Cart
sales@molnova.com
p53-MDM2-IN-1
CAS No. 381717-91-5
p53-MDM2-IN-1( —— )
Catalog No. M36397 CAS No. 381717-91-5
p53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 5MG | 466 | In Stock |
|
| 10MG | 679 | In Stock |
|
| 25MG | 1003 | In Stock |
|
| 50MG | 1362 | In Stock |
|
| 100MG | 1782 | In Stock |
|
| 500MG | 3573 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namep53-MDM2-IN-1
-
NoteResearch use only, not for human use.
-
Brief Descriptionp53-MDM2-IN-1 (Example 30), an inhibitor of the p53-MDM2/X protein interaction, exhibits a K i value of 23.35 μM and holds potential for applications in anti-tumor research.
-
Descriptionp53-MDM2-IN-1 (Example 30) is an inhibitor of p53-MDM2/X protein interaction with an Ki value of 23.35 μM. p53-MDM2-IN-1 can be used for anti-tumor research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetMDM2-p53
-
RecptorMdm2 | p53
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number381717-91-5
-
Formula Weight421.88
-
Molecular FormulaC23H20ClN3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=O)(C=1C(N(CCCN2C=CN=C2)C(=O)C1O)C3=CC=C(Cl)C=C3)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang W, et al. Pyrrylketone compound and application thereof as drug. China. CN102603717.
molnova catalog
related products
-
p53 17-26
This peptide is amino acids 17 to 26 fragment of p53, the Mdm-2 binding domain of p53 known also as p53N. This sequence contains all of the residues that contact the binding domain of Mdm-2.
-
p53-Mdm2 inhibitor 4
p53-Mdm2 inhibitor 4 inhibits the p53-MDM2 protein-protein interaction.
-
PRIMA-1
A specific mutant p53 reactivator that induces apoptosis and enhances chemotherapeutic cytotoxicity in cancer cell lines.
